Carin Wittnich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Carin Wittnich has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Michael Belanger
Department of Surgery and Physiology, University of Toronto, Ontario, Canada
7 shared publications Michael P. Belanger
Department of Surgery
6 shared publicationsMichael Belanger
B Department of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada
4 shared publicationsW Jack Wallen
4 shared publicationsW. Jack Wallen
Department of Physiology, University of Toronto, Canada M5S 1A8
4 shared publicationsLuke Tan
B Department of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada
3 shared publications
Latest Publications
- 1 June 2026
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 50 (2) , 627-635
The development and impact of an innovative graduate program to promote entry to physiology-related careers: the Master of Health Science in Medical Physiology
To respond to emerging needs for new skills and to provide additional career paths for physiology graduates, we present the development, implementation, and outcomes of a new course-based, professional Master’s program in physiology. Our novel multidisciplinary approach combines advanced physiology knowledge with applications, including big data analysis, commercialization initiatives, and clinical interventions, and prepares graduates for direct entry into related careers in health.
- 1 June 2026
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 50 (2) , 627-635
The development and impact of an innovative graduate program to promote entry to physiology-related careers: the Master of Health Science in Medical Physiology
To respond to emerging needs for new skills and to provide additional career paths for physiology graduates, we present the development, implementation, and outcomes of a new course-based, professional Master’s program in physiology. Our novel multidisciplinary approach combines advanced physiology knowledge with applications, including big data analysis, commercialization initiatives, and clinical interventions, and prepares graduates for direct entry into related careers in health.
- Open Access
Water-Column Zone Impacts Non-Essential Heavy Metal Accumulation in Fish Occupying Different Zones
The Gulf of Maine and Bay of Fundy have documented increases in heavy metals with specific properties, resulting in differing concentrations throughout the water column. Whether this impacts metal accumulation in fish that occupy different zones of the water column is unknown; as such, this was the focus of this work. Commercially harvested fish spanning the epipelagic, mesopelagic, and demersal zones of the water column had weight for length (LWR) recorded and biopsies taken. Demersal fish had the highest levels of arsenic and nickel, whereas fish in the epipelagic and demersal zones showed the highest levels of cadmium, lead, mercury and thallium. Compared to historic data, LWR was reduced in one epipelagic species (15%) and two demersal species (24%, 25%). Mesopelagic species showed increased LWR (23%) concurrent with overall lowest metal exposure. These findings demonstrate that fish accumulate non-essential metals at levels dependent on location in the water column, impacting their growth.
Open AccessWater-Column Zone Impacts Non-Essential Heavy Metal Accumulation in Fish Occupying Different Zones
The Gulf of Maine and Bay of Fundy have documented increases in heavy metals with specific properties, resulting in differing concentrations throughout the water column. Whether this impacts metal accumulation in fish that occupy different zones of the water column is unknown; as such, this was the focus of this work. Commercially harvested fish spanning the epipelagic, mesopelagic, and demersal zones of the water column had weight for length (LWR) recorded and biopsies taken. Demersal fish had the highest levels of arsenic and nickel, whereas fish in the epipelagic and demersal zones showed the highest levels of cadmium, lead, mercury and thallium. Compared to historic data, LWR was reduced in one epipelagic species (15%) and two demersal species (24%, 25%). Mesopelagic species showed increased LWR (23%) concurrent with overall lowest metal exposure. These findings demonstrate that fish accumulate non-essential metals at levels dependent on location in the water column, impacting their growth.
- Open Access
- 5 January 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 230, 113153
Anadromous fish as biomarkers for the combined impact of marine and freshwater heavy metal pollution
- 5 January 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 230, 113153
Open AccessAnadromous fish as biomarkers for the combined impact of marine and freshwater heavy metal pollution
- 1 January 2022
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 322 (1) , H1-H7
Cardiac structures in marine animals provide insight on potential directions for interventions for pediatric congenital heart defects
Despite recent advances in pediatric diagnosis and surgical intervention, mortality and morbidity continue to be a prevalent issue in both tetralogy of Fallot (ToF) and hypoplastic left heart syndrome (HLHS). Therefore, novel approaches to studying both of these conditions are warranted. Investigating cardiac anatomical features of different species in the animal kingdom that are similar to the defects and complications present in ToF and HLHS (as well as others) could serve as a new avenue for improving the management of congenital heart diseases (CHD). This review reveals that although some structures found in HLHS and ToF are pathological, similar structures can be found in diving mammals and reptiles that are adaptive. Pathological aortic dilation in CHD resembles the aortic bulb present in diving mammals, but the latter is more elastic and distensible compared with the former. The unrepaired HLHS heart resembles the univentricular heart of non-crocodilian reptiles. Right ventricle hypertrophy is pathological in HLHS and ToF, but in contrast, adaptive in crocodilians and diving mammals. Lastly, the increased pulmonary resistance due to pulmonary stenosis in ToF is comparable with increased pulmonary resistance in crocodilians due to the presence of an active valve proximal to the pulmonary valve. Some of these anatomical structures could potentially be adapted for palliative surgery in children with HLHS or ToF. Moreover, further investigating the underlying molecular signals responsible for the adaptive tissue responses seen in other species may also be useful for developing novel strategies for preventing some of the complications that occur after surgical repair in both of these congenital heart diseases.
- 1 January 2022
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 322 (1) , H1-H7
Cardiac structures in marine animals provide insight on potential directions for interventions for pediatric congenital heart defects
Despite recent advances in pediatric diagnosis and surgical intervention, mortality and morbidity continue to be a prevalent issue in both tetralogy of Fallot (ToF) and hypoplastic left heart syndrome (HLHS). Therefore, novel approaches to studying both of these conditions are warranted. Investigating cardiac anatomical features of different species in the animal kingdom that are similar to the defects and complications present in ToF and HLHS (as well as others) could serve as a new avenue for improving the management of congenital heart diseases (CHD). This review reveals that although some structures found in HLHS and ToF are pathological, similar structures can be found in diving mammals and reptiles that are adaptive. Pathological aortic dilation in CHD resembles the aortic bulb present in diving mammals, but the latter is more elastic and distensible compared with the former. The unrepaired HLHS heart resembles the univentricular heart of non-crocodilian reptiles. Right ventricle hypertrophy is pathological in HLHS and ToF, but in contrast, adaptive in crocodilians and diving mammals. Lastly, the increased pulmonary resistance due to pulmonary stenosis in ToF is comparable with increased pulmonary resistance in crocodilians due to the presence of an active valve proximal to the pulmonary valve. Some of these anatomical structures could potentially be adapted for palliative surgery in children with HLHS or ToF. Moreover, further investigating the underlying molecular signals responsible for the adaptive tissue responses seen in other species may also be useful for developing novel strategies for preventing some of the complications that occur after surgical repair in both of these congenital heart diseases.
- 1 October 2017
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 95 (10) , 1177-1182
Does young age really put the heart at risk?
Despite significant advances in the management and treatment of heart disease in children, there continue to be patients who have worse outcomes than might be expected. A number of risk factors that could be responsible have been identified. Evidence-based findings will be reviewed, including whether young age and (or) reduced body weight exacerbate these responses. For example, newborn children undergoing congenital cardiac surgery are known to have worse outcomes than older children. Evidence exists that newborn hearts do not tolerate ischemia as well as adult hearts, developing irreversible injury sooner and exhibiting at-risk metabolic profiles. As well, in response to the administration of heparin, elevations in free fatty acids occur during congenital heart surgery in children, which can have detrimental effects on the heart. Furthermore, myocardial energetic state has also been suggested to impact outcomes. Unfavourable energetic profiles were correlated to lower body weights in the same age healthy newborn piglet model. Newborn children suffering from congenital heart disease, with lower body weights, also had lower myocardial energetic state and this correlated with longer postoperative ventilatory support as well as a trend to longer intensive care unit stay. These findings imply that unfavourable myocardial metabolic profiles could contribute to postoperative complications.
- 1 October 2017
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 95 (10) , 1177-1182
Does young age really put the heart at risk?
Despite significant advances in the management and treatment of heart disease in children, there continue to be patients who have worse outcomes than might be expected. A number of risk factors that could be responsible have been identified. Evidence-based findings will be reviewed, including whether young age and (or) reduced body weight exacerbate these responses. For example, newborn children undergoing congenital cardiac surgery are known to have worse outcomes than older children. Evidence exists that newborn hearts do not tolerate ischemia as well as adult hearts, developing irreversible injury sooner and exhibiting at-risk metabolic profiles. As well, in response to the administration of heparin, elevations in free fatty acids occur during congenital heart surgery in children, which can have detrimental effects on the heart. Furthermore, myocardial energetic state has also been suggested to impact outcomes. Unfavourable energetic profiles were correlated to lower body weights in the same age healthy newborn piglet model. Newborn children suffering from congenital heart disease, with lower body weights, also had lower myocardial energetic state and this correlated with longer postoperative ventilatory support as well as a trend to longer intensive care unit stay. These findings imply that unfavourable myocardial metabolic profiles could contribute to postoperative complications.
- 25 June 2015
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 29 (4) , 347-353
The Role of 17β-Estradiol in Myocardial Hypertrophy in Females in the Presence and Absence of Hypertension
There are gender-differences in the development of cardiac hypertrophy, which appear to be related, in part, to sex hormones. This report gives an overview of this relationship and reports on original data assessing how varying levels of plasma 17β-estradiol determine relative heart size, in vivo function, in hypertensive versus normotensive rats. Female spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were either surgically neutered or sham operated at 21 days of age. A subgroup of neutered females received 17β-estradiol replacement. At 6 months, in vivo heart function was measured, the heart/body weight ratio (mg/g) was assessed as a measure of hypertrophy and correlated with plasma 17β-estradiol. There was a significant positive relationship between plasma 17β-estradiol and heart/body weight ratio in both WKY (R = 0.509, P = 0.011) and SHR females (R = 0.359, P = 0.032). Interestingly, the slope of this relationship was 2-fold steeper in the WKY females, suggesting a blunted effect in the SHR, whose hearts also had 35 % lower ERβ content. With increasing plasma estradiol levels, WKY females showed improved LV function while SHR females showed impaired LV relaxation. Plasma estradiol modulates relative heart mass in both normotensive and hypertensive female rats. With any increase in plasma 17β-estradiol, hypertensive females show a blunted response compared with the normotensive females, which may be related to a reduced estrogen receptor expression in the presence of hypertension. In contrast to normotensive females, hypertensive females showed impaired function with increases in plasma 17β-estradiol.
- 25 June 2015
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 29 (4) , 347-353
The Role of 17β-Estradiol in Myocardial Hypertrophy in Females in the Presence and Absence of Hypertension
There are gender-differences in the development of cardiac hypertrophy, which appear to be related, in part, to sex hormones. This report gives an overview of this relationship and reports on original data assessing how varying levels of plasma 17β-estradiol determine relative heart size, in vivo function, in hypertensive versus normotensive rats. Female spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were either surgically neutered or sham operated at 21 days of age. A subgroup of neutered females received 17β-estradiol replacement. At 6 months, in vivo heart function was measured, the heart/body weight ratio (mg/g) was assessed as a measure of hypertrophy and correlated with plasma 17β-estradiol. There was a significant positive relationship between plasma 17β-estradiol and heart/body weight ratio in both WKY (R = 0.509, P = 0.011) and SHR females (R = 0.359, P = 0.032). Interestingly, the slope of this relationship was 2-fold steeper in the WKY females, suggesting a blunted effect in the SHR, whose hearts also had 35 % lower ERβ content. With increasing plasma estradiol levels, WKY females showed improved LV function while SHR females showed impaired LV relaxation. Plasma estradiol modulates relative heart mass in both normotensive and hypertensive female rats. With any increase in plasma 17β-estradiol, hypertensive females show a blunted response compared with the normotensive females, which may be related to a reduced estrogen receptor expression in the presence of hypertension. In contrast to normotensive females, hypertensive females showed impaired function with increases in plasma 17β-estradiol.
- 1 June 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (6) , 2178
Invited Commentary.
- 1 June 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (6) , 2178
Invited Commentary.
- 13 February 2013
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 465 (5) , 719-729
Sex differences in myocardial metabolism and cardiac function: an emerging concept
There is substantial evidence that there are dramatic sex-related differences in the incidence of cardiovascular disease, apparently related to the presence of steroid hormones. This is supported by the discovery of steroid hormone receptors in the heart and vasculature. More controversial is the area of sex-related differences in cardiac metabolism and function. A number of human and animal studies have demonstrated that estrogen and testosterone have cardiac metabolic effects. Additionally, research shows females have higher heart rates and various indices of function, including cardiac output and stroke volume, compared with males. However, some controversy exists, as other studies report that function in isolated muscle preparations is lower in females versus males. The reasons for these differences may reflect effects of sex hormones that are dependent on the conditions being studied. Cardiac function is reduced in postmenopausal females, suggesting that female sex hormones, specifically estrogen and progesterone, influence cardiac function. Apart from its well-documented vasodilatory effects, estrogen has also been shown to have negative inotropic effects and to reduce Ca2+ transients in cardiomyocytes. Similar results have been found for progesterone. Several studies show that testosterone administration appears to increase cardiac performance, while others show that it increases the stiffness of the ventricle due to increased collagen synthesis, thereby reducing diastolic performance. This review will discuss current evidence suggesting sex-related differences in cardiac metabolism and its energetics and function and will present the potential role of the principal sex steroid hormones.
- 13 February 2013
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 465 (5) , 719-729
Sex differences in myocardial metabolism and cardiac function: an emerging concept
There is substantial evidence that there are dramatic sex-related differences in the incidence of cardiovascular disease, apparently related to the presence of steroid hormones. This is supported by the discovery of steroid hormone receptors in the heart and vasculature. More controversial is the area of sex-related differences in cardiac metabolism and function. A number of human and animal studies have demonstrated that estrogen and testosterone have cardiac metabolic effects. Additionally, research shows females have higher heart rates and various indices of function, including cardiac output and stroke volume, compared with males. However, some controversy exists, as other studies report that function in isolated muscle preparations is lower in females versus males. The reasons for these differences may reflect effects of sex hormones that are dependent on the conditions being studied. Cardiac function is reduced in postmenopausal females, suggesting that female sex hormones, specifically estrogen and progesterone, influence cardiac function. Apart from its well-documented vasodilatory effects, estrogen has also been shown to have negative inotropic effects and to reduce Ca2+ transients in cardiomyocytes. Similar results have been found for progesterone. Several studies show that testosterone administration appears to increase cardiac performance, while others show that it increases the stiffness of the ventricle due to increased collagen synthesis, thereby reducing diastolic performance. This review will discuss current evidence suggesting sex-related differences in cardiac metabolism and its energetics and function and will present the potential role of the principal sex steroid hormones.
- 1 August 2011
- Published by Springer Nature in Pediatric Research
- Vol. 70 (2) , 148-152
Sex Differences in Newborn Myocardial Metabolism and Response to Ischemia
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.
- 1 August 2011
- Published by Springer Nature in Pediatric Research
- Vol. 70 (2) , 148-152
Sex Differences in Newborn Myocardial Metabolism and Response to Ischemia
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.